95299-17-5

Basic information

• Product Name: Methyl2,4-difluorophenylacetate97%
• Synonyms: Methyl2,4-difluorophenylacetate97%;Methyl 2,4-difluorobenzeneacetate;methyl 2-(2,4-difluorophenyl)acetate;Methyl 2,4-difluorophenylacetate
• CAS NO: 95299-17-5
• Molecular Formula: C₉H₈F₂O₂
• Molecular Weight: 186.1554264
• Mol File: 95299-17-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 206.0±25.0 °C(Predicted)
• Appearance: /
• Density: 1.235±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Methyl2,4-difluorophenylacetate97%(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl2,4-difluorophenylacetate97%(95299-17-5)
• EPA Substance Registry System: Methyl2,4-difluorophenylacetate97%(95299-17-5)

Safety Data

• Hazardous Substances Data: 95299-17-5(Hazardous Substances Data)

Usage

General Description

Methyl 2,4-difluorophenylacetate 97% is a chemical compound that is composed of 97% pure methyl 2,4-difluorophenylacetate. Methyl2,4-difluorophenylacetate97% is a derivative of phenylacetic acid and is commonly used in the pharmaceutical industry for the synthesis of various drugs. It has a molecular formula of C9H8F2O2 and a molecular weight of 184.16 g/mol. Methyl 2,4-difluorophenylacetate 97% is known for its high purity and is often used as a key intermediate in the production of pharmaceuticals and other organic compounds. It is important to handle this chemical with care and follow proper safety protocols when working with it.

Upstream product

• 67-56-1 methanol 
• 81228-09-3 2,4-difluorophenylacetic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 960371-20-4 dimethyl 1-(2,4-difluorophenyl)-4-oxocyclohexane-1,3-dicarboxylate 
• 1240469-67-3 methyl 5-chloro-2-(2,4-difluorophenyl)pentanoate 
• 868049-68-7 1-(2,4-difluorophenyl)-2-methylpropan-2-ol 
• 793657-84-8 2-(2,4-difluorophenyl)piperazine 
• 1246550-88-8 3-(2,4-difluorophenyl)piperazin-2-one 
• 1266680-51-6 methyl bromo(2,4-difluorophenyl)acetate 
• 1374668-02-6 3-(cyclopropylmethyl)-7-{[3-(2,4-difluorophenyl)piperazin-1-yl]methyl}-8-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine 

Relevant articles and documents

PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS

Compounds of Formula (0), Formula (I), and Formula (II) and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

The present invention relates to novel triazolo[4,3-a]pyridine derivatives of Formula (I) wherein all radicals are as defined in the claims. The compounds according to the invention are positive allosteric modulators of the metabotropic glutamate receptor subtype 2 ("mGluR2"), which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds for the prevention or treatment of neurological and psychiatric disorders and diseases in which mGluR2 is involved.

Benzamide derivatives and uses related thereto

Benzamide derivatives of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: wherein R1, R2, R3, R4, R5, R6, R7, R8, and n are as defined herein.